High-Precision Cell Therapy Shows Efficacy in Hematologic Cancers

(MedPage Today) -- Orca-T is a cell therapy product that has demonstrated encouraging efficacy in patients with hematologic cancers in phase I/II studies. A phase III randomized trial that is comparing the product with standard-of-care hematopoietic...